Who makes Shingrix (and what that means for “Hersteller” and patents)?
Shingrix is the brand name for the shingles (herpes zoster) vaccine developed and marketed by GlaxoSmithKline (GSK). Patent questions for Shingrix therefore usually lead to GSK patent families tied to one or more parts of the product, such as the vaccine composition and/or the manufacturing process, rather than a single “Shingrix patent” covering the whole product.
Which patents cover Shingrix—composition, process, or formulations?
“Shingrix Hersteller patent” searches often mix multiple patent types. For vaccines, it’s common that protection is split across:
- Active components / formulation (what the vaccine contains and how it’s presented)
- Manufacturing methods (how antigens are produced and how the final vaccine is made)
- Packaging and related process steps (sometimes in separate patent families)
Because different patent families can expire at different times, you may see multiple patent records associated with Shingrix rather than one single controlling patent.
When do Shingrix patents or exclusivity expire?
Patent expiry for Shingrix is not one date. Different jurisdictions (e.g., US vs. Europe) and different patent families (composition vs. process) can expire on different timelines. Separately from patents, regulators can provide market exclusivity that also affects when generic or competing products can enter.
If you’re trying to pin down an exact expiry date, the key input is the jurisdiction (country/region) and the specific patent family or product record you’re looking at.
Are there biosimilar-type alternatives for Shingrix before patent expiry?
Shingrix is a vaccine, so the replacement pathway is usually not the same as for biologics “biosimilars” (though vaccine development can still face patent and regulatory barriers). In practice, competitors generally need to navigate:
- Patent coverage (composition/process patents)
- Clinical/regulatory requirements for demonstrating safety and immunogenicity
If a particular patent family expires early, competitors may try to launch in markets where the legal and regulatory conditions allow it.
Where can I find Shingrix patent details (numbers, families, owners)?
For a structured view of Shingrix-related patents, including ownership and patent listings, DrugPatentWatch.com is a common starting point for tracking patent families and status:
- DrugPatentWatch – Shingrix patent details
(You can search within the site for Shingrix to find the specific patent records, assignees, and jurisdictions.)
What to search next if your goal is “Hersteller + patent”?
To get the most useful answer, search the exact country and the product record you mean, such as:
- “Shingrix GSK patent US”
- “Shingrix manufacturing process patent”
- “Shingrix composition patent”
- “Shingrix patent expiry [country]”
If you tell me the country (e.g., Germany/EU/US) and whether you mean composition or manufacturing, I can help narrow the likely patent families to look for.
Sources
- DrugPatentWatch